Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 1
2006 3
2007 2
2008 2
2009 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
Gnant M, Mlineritsch B, Schippinger W, Luschin-Ebengreuth G, Pöstlberger S, Menzel C, Jakesz R, Seifert M, Hubalek M, Bjelic-Radisic V, Samonigg H, Tausch C, Eidtmann H, Steger G, Kwasny W, Dubsky P, Fridrik M, Fitzal F, Stierer M, Rücklinger E, Greil R; ABCSG-12 Trial Investigators, Marth C. Gnant M, et al. N Engl J Med. 2009 Feb 12;360(7):679-91. doi: 10.1056/NEJMoa0806285. N Engl J Med. 2009. PMID: 19213681 Free article. Clinical Trial.
A multigenic approach to predict breast cancer risk.
Gerger A, Langsenlehner U, Renner W, Weitzer W, Eder T, Yazdani-Biuki B, Hofmann G, Samonigg H, Krippl P. Gerger A, et al. Among authors: Weitzer W. Breast Cancer Res Treat. 2007 Aug;104(2):159-64. doi: 10.1007/s10549-006-9408-4. Epub 2006 Oct 21. Breast Cancer Res Treat. 2007. PMID: 17058024
Integrin alpha-2 and beta-3 gene polymorphisms and colorectal cancer risk.
Gerger A, Hofmann G, Langsenlehner U, Renner W, Weitzer W, Wehrschütz M, Wascher T, Samonigg H, Krippl P. Gerger A, et al. Among authors: Weitzer W. Int J Colorectal Dis. 2009 Feb;24(2):159-63. doi: 10.1007/s00384-008-0587-9. Epub 2008 Oct 3. Int J Colorectal Dis. 2009. PMID: 18836731
Effect of capecitabine on mean corpuscular volume of red blood cells.
Vrecl R, Gerold M, Melzer S, Rainer W, Weitzer W. Vrecl R, et al. Among authors: Weitzer W. Am J Clin Oncol. 2005 Oct;28(5):534. doi: 10.1097/01.coc.0000173186.49719.b1. Am J Clin Oncol. 2005. PMID: 16199999 No abstract available.
Genetic variants of the sulfotransferase 1A1 and breast cancer risk.
Langsenlehner U, Krippl P, Renner W, Yazdani-Biuki B, Eder T, Wolf G, Wascher TC, Paulweber B, Weitzer W, Samonigg H. Langsenlehner U, et al. Among authors: Weitzer W. Breast Cancer Res Treat. 2004 Sep;87(1):19-22. doi: 10.1023/B:BREA.0000041574.90735.ea. Breast Cancer Res Treat. 2004. PMID: 15377847
COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic for molecular markers.
Langsenlehner U, Gerger A, Weitzer W, Krippl P. Langsenlehner U, et al. Among authors: Weitzer W. Breast Cancer Res Treat. 2007 Jan;101(2):247. doi: 10.1007/s10549-006-9291-z. Epub 2006 Jul 13. Breast Cancer Res Treat. 2007. PMID: 16838111 No abstract available.
The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk.
Langsenlehner U, Yazdani-Biuki B, Eder T, Renner W, Wascher TC, Paulweber B, Weitzer W, Samonigg H, Krippl P. Langsenlehner U, et al. Among authors: Weitzer W. Clin Cancer Res. 2006 Feb 15;12(4):1392-4. doi: 10.1158/1078-0432.CCR-05-2055. Clin Cancer Res. 2006. PMID: 16489098 Free article.
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.
Gnant M, Mlineritsch B, Luschin-Ebengreuth G, Kainberger F, Kässmann H, Piswanger-Sölkner JC, Seifert M, Ploner F, Menzel C, Dubsky P, Fitzal F, Bjelic-Radisic V, Steger G, Greil R, Marth C, Kubista E, Samonigg H, Wohlmuth P, Mittlböck M, Jakesz R; Austrian Breast and Colorectal Cancer Study Group (ABCSG). Gnant M, et al. Lancet Oncol. 2008 Sep;9(9):840-9. doi: 10.1016/S1470-2045(08)70204-3. Epub 2008 Aug 19. Lancet Oncol. 2008. PMID: 18718815 Clinical Trial.
The 870G>A polymorphism of the cyclin D1 gene is not associated with breast cancer.
Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Weitzer W, Leithner A, Samonigg H. Krippl P, et al. Among authors: Weitzer W. Breast Cancer Res Treat. 2003 Dec;82(3):165-8. doi: 10.1023/B:BREA.0000004372.20461.33. Breast Cancer Res Treat. 2003. PMID: 14703063
The common 677C>T gene polymorphism of methylenetetrahydrofolate reductase gene is not associated with breast cancer risk.
Langsenlehner U, Krippl P, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Weitzer W, Samonigg H. Langsenlehner U, et al. Among authors: Weitzer W. Breast Cancer Res Treat. 2003 Sep;81(2):169-72. doi: 10.1023/A:1025752420309. Breast Cancer Res Treat. 2003. PMID: 14572159
Feedback